In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo Nordisk’s Wegovy shed more than 33 pounds ...
Anthony A. Bavry, M.D., M.P.H.; Deepak L. Bhatt, M.D., F.A.C.C. Overweight adults were randomized to one of four diets, based on proportion of fat, protein, and ...
People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly-sponsored study, compared with a 13.7% loss for Wegovy patients, Lilly said Wednesday.